-
If you purchased shares of ZS Pharma Inc (NASDAQ:ZSPH) and currently hold any of those NASDAQ:ZSPH shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
November 16, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of ZS Pharma Inc (NASDAQ:ZSPH), was announced concerning whether the takeover of ZS Pharma Inc. by AstraZeneca for $90 per share is unfair to NASDAQ:ZSPH stockholders.
The investigation by a law firm concerns whether certain officers and directors of ZS Pharma Inc breached their fiduciary duties owed to NASDAQ:ZSPH investors in connection with the proposed acquisition.
On November 6, 2015, AstraZeneca announced hat it has entered into an agreement to acquire ZS Pharma Inc (NASDAQ:ZSPH). Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value.
However, the investigation concerns whether the offer is unfair to NASDAQ:ZSPH stockholders. More specifically, the investigation concerns whether the ZS Pharma Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
